1. Home
  2. DBD vs GRDN Comparison

DBD vs GRDN Comparison

Compare DBD & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBD
  • GRDN
  • Stock Information
  • Founded
  • DBD 1859
  • GRDN 2004
  • Country
  • DBD United States
  • GRDN United States
  • Employees
  • DBD N/A
  • GRDN N/A
  • Industry
  • DBD EDP Services
  • GRDN Retail-Drug Stores and Proprietary Stores
  • Sector
  • DBD Technology
  • GRDN Consumer Staples
  • Exchange
  • DBD Nasdaq
  • GRDN Nasdaq
  • Market Cap
  • DBD 2.1B
  • GRDN 1.7B
  • IPO Year
  • DBD N/A
  • GRDN 2024
  • Fundamental
  • Price
  • DBD $61.49
  • GRDN $27.99
  • Analyst Decision
  • DBD Strong Buy
  • GRDN Strong Buy
  • Analyst Count
  • DBD 3
  • GRDN 2
  • Target Price
  • DBD $76.67
  • GRDN $32.00
  • AVG Volume (30 Days)
  • DBD 206.7K
  • GRDN 363.3K
  • Earning Date
  • DBD 11-05-2025
  • GRDN 11-10-2025
  • Dividend Yield
  • DBD N/A
  • GRDN N/A
  • EPS Growth
  • DBD 43573.14
  • GRDN N/A
  • EPS
  • DBD 1.35
  • GRDN 0.64
  • Revenue
  • DBD $3,690,400,000.00
  • GRDN $1,389,638,000.00
  • Revenue This Year
  • DBD $3.09
  • GRDN $16.33
  • Revenue Next Year
  • DBD $2.56
  • GRDN $2.10
  • P/E Ratio
  • DBD $45.56
  • GRDN $43.74
  • Revenue Growth
  • DBD N/A
  • GRDN 18.68
  • 52 Week Low
  • DBD $34.88
  • GRDN $17.78
  • 52 Week High
  • DBD $66.28
  • GRDN $37.43
  • Technical
  • Relative Strength Index (RSI)
  • DBD 51.73
  • GRDN 48.87
  • Support Level
  • DBD $64.26
  • GRDN $29.81
  • Resistance Level
  • DBD $65.44
  • GRDN $32.00
  • Average True Range (ATR)
  • DBD 2.36
  • GRDN 1.79
  • MACD
  • DBD 0.04
  • GRDN -0.20
  • Stochastic Oscillator
  • DBD 60.12
  • GRDN 5.82

About DBD Diebold Nixdorf Incorporated Common stock

Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

Share on Social Networks: